Detalhe da pesquisa
1.
Sunitinib for metastatic progressive phaeochromocytomas and paragangliomas: results from FIRSTMAPPP, an academic, multicentre, international, randomised, placebo-controlled, double-blind, phase 2 trial.
Lancet
; 403(10431): 1061-1070, 2024 Mar 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38402886
2.
Bevacizumab plus FOLFIRI after failure of platinum-etoposide first-line chemotherapy in patients with advanced neuroendocrine carcinoma (PRODIGE 41-BEVANEC): a randomised, multicentre, non-comparative, open-label, phase 2 trial.
Lancet Oncol
; 24(3): 297-306, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36739879
3.
Clinical activity of CC-90011, an oral, potent, and reversible LSD1 inhibitor, in advanced malignancies.
Cancer
; 128(17): 3185-3195, 2022 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35737639
4.
Metastatic Potential and Survival of Duodenal and Pancreatic Tumors in Multiple Endocrine Neoplasia Type 1: A GTE and AFCE Cohort Study (Groupe d'étude des Tumeurs Endocrines and Association Francophone de Chirurgie Endocrinienne).
Ann Surg
; 272(6): 1094-1101, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30585820
5.
A single-center experience with pancreatic cystic neuroendocrine tumors.
World J Surg Oncol
; 18(1): 208, 2020 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32799893
6.
Long-term Follow-up of MEN1 Patients Who Do Not Have Initial Surgery for Small ≤2 cm Nonfunctioning Pancreatic Neuroendocrine Tumors, an AFCE and GTE Study: Association Francophone de Chirurgie Endocrinienne & Groupe d'Etude des Tumeurs Endocrines.
Ann Surg
; 268(1): 158-164, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28263205
7.
Chemotherapy for Well-Differentiated Pancreatic Neuroendocrine Tumours with a Ki-67 Index ≥10%: Is There a More Effective Antitumour Regimen? A Retrospective Multicentre Study of the French Group of Endocrine Tumours (GTE).
Neuroendocrinology
; 106(1): 38-46, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-28152531
8.
Clinical and Biomarker Evaluations of Sunitinib in Patients with Grade 3 Digestive Neuroendocrine Neoplasms.
Neuroendocrinology
; 107(1): 24-31, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29518779
9.
Management of asymptomatic sporadic non-functioning pancreatic neuroendocrine neoplasms no larger than 2â cm: interim analysis of prospective ASPEN trial.
Br J Surg
; 109(12): 1186-1190, 2022 11 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-35986682
10.
The value of a rapid contrast-enhanced angio-MRI protocol in the detection of head and neck paragangliomas in SDHx mutations carriers: a retrospective study on behalf of the PGL.EVA investigators.
Eur Radiol
; 26(6): 1696-704, 2016 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-26427697
11.
Higher risk of death among MEN1 patients with mutations in the JunD interacting domain: a Groupe d'etude des Tumeurs Endocrines (GTE) cohort study.
Hum Mol Genet
; 22(10): 1940-8, 2013 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-23376981
12.
[Neuroendocrine well-differentiated pancreatic tumors]. / Tumeurs neuro-endocrines bien différenciées du pancreas.
Rev Prat
; 65(4): 461-5, 2015 Apr.
Artigo
em Francês
| MEDLINE | ID: mdl-26058180
13.
Is basal ultrasensitive measurement of calcitonin capable of substituting for the pentagastrin-stimulation test?
Clin Endocrinol (Oxf)
; 78(3): 358-64, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-22913268
14.
Transarterial chemoembolization (TACE) for neuroendocrine liver metastasis (NELM): Predictive value of volumetric arterial enhancement (VAE) on baseline MRI.
Bull Cancer
; 110(3): 308-319, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36732142
15.
Outcome of nonfunctioning pancreatic neuroendocrine tumors after initial surveillance or surgical resection: a single-center observational study.
Ann Gastroenterol
; 36(6): 686-693, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38023974
16.
Genetic testing in prolactinomas: a cohort study.
Eur J Endocrinol
; 189(6): 567-574, 2023 Dec 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37956455
17.
Pasireotide for Refractory Hypoglycemia in Malignant Insulinoma- Case Report and Review of the Literature.
Front Endocrinol (Lausanne)
; 13: 860614, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35518928
18.
Efficacy of FOLFOX Chemotherapy in Metastatic Enteropancreatic Neuroendocrine Tumors.
Anticancer Res
; 41(4): 2071-2078, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33813416
19.
Kinome rewiring during acquired drug resistance in neuroendocrine neoplasms.
Endocr Relat Cancer
; 28(1): 39-51, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33112824
20.
Intermittent versus continuous administration of pazopanib in progressive radioiodine refractory thyroid carcinoma: Final results of the randomised, multicenter, open-label phase II trial PAZOTHYR.
Eur J Cancer
; 157: 153-164, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34509954